ANDA Process: Legal Requirements for Generic Drug Approval
Explore the legal and regulatory requirements of the ANDA process for generic drug approval. Learn about Hatch-Waxman, bioequivalence, patent certifications, and FDA fees.
Tag: bioequivalence
Are Pharmacokinetic Studies the Gold Standard for Generic Drug Equivalence?
Explore whether pharmacokinetic studies are truly the gold standard for generic drug equivalence. Learn about bioequivalence rules, NTI drugs, and future regulatory shifts.
How the FDA Ensures Generic Drugs Work the Same as Brand-Name Medications
Discover how the FDA guarantees generic drugs match brand-name efficacy through bioequivalence testing, the ANDA process, and strict manufacturing standards under the Hatch-Waxman Act.
Managing Patient Hesitation About Generics: Proven Communication Strategies for Pharmacists
Patients often hesitate to take generic medications due to misconceptions about effectiveness and appearance. Pharmacists can significantly improve acceptance by using evidence-based communication strategies like Ask-Tell-Ask, personalized endorsements, and visual aids. Proven techniques increase compliance, reduce costs, and build lasting trust.
Population Pharmacokinetics: Using Real-World Data to Prove Drug Equivalence
Population pharmacokinetics uses real-world patient data to prove drug equivalence across diverse populations, replacing outdated methods that relied on healthy volunteers. It's now the gold standard for biosimilars, narrow therapeutic index drugs, and special populations.